“ Dexmedetomidine Inhibits Inflammation and Angiogenesis and Alleviates Esophageal Cancer Progression through ITGA6 PI3K AKT Pathway: Dexmedetomidine Inhibits Esophageal Cancer Progression”. Indian Journal of Experimental Biology (IJEB), vol. 64, no. 01, Feb. 2026, pp. 15-32, https://doi.org/10.56042/ijeb.v64i01.22881.